Beyond Biotech podcast 26: CellCentric, MicrofluidX, Potter Clarkson
This week, we have three guests. We have conversations with Antoine Espinet, CEO of MicrofluidX;…
As one of the biggest success stories of the 21st century, gene therapy is providing hope for treating diseases that once seemed incurable. Any genetic mutation causing disease could theoretically be fixed by inserting a new copy of the faulty gene. This means that gene therapy has the potential to treat some previously incurable conditions with a single dose.
By 2025, the FDA expects to approve between 10 and 20 gene therapies each year, and we are already seeing an increase in the number of approvals today. However, the field continues to face a number of obstacles ranging from safety concerns to manufacturing shortages. Read on to get the latest in the gene therapy field.
Gene Therapy Industry Report 2021
In this report, we take a closer look at the growing gene therapy market, current development and manufacturing challenges, and the exciting future ahead for this industry.
Go to ReportThis week, we have three guests. We have conversations with Antoine Espinet, CEO of MicrofluidX;…
CSL says the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)…
Over the decades, the EU has spearheaded the adoption of advanced therapy medicinal products (ATMPs)…
Myrtelle Inc., a clinical stage gene therapy company, has announced that the European Medicines Agency…
Replay, a genome writing company, today announced the launch of Kaleibe, an HSV gene therapy…
MicrofluidX (MFX), a U.K. based provider of next-generation bioreactors for cell research and manufacturing, has…
Polyplus has announced the completion of an acquisition of Belgian Xpress Biologics to expand plasmid…
MaxCyte, Inc. and Curamys have announced the signing of a strategic platform license. MaxCyte is…
SparingVision today announces that the U.S. Food and Drug Administration (FDA) has cleared its Investigational…
Sensorion a clinical-stage biotechnology company has announced that the US Food and Drug Administration (FDA)…
BioPharma Dynamics have expanded their portfolio for the cell and gene therapy market to offer…
The majority of known rare genetic diseases affect children, and gene therapies could help them…